{"id":"https://openalex.org/W2803877790","doi":"https://doi.org/10.1055/s-0037-1610140","title":"A Divergent Nickel-Catalyzed Synthesis of Quinazolinediones and Benzoxazinone Imines","display_name":"A Divergent Nickel-Catalyzed Synthesis of Quinazolinediones and Benzoxazinone Imines","publication_year":2018,"publication_date":"2018-05-17","ids":{"openalex":"https://openalex.org/W2803877790","doi":"https://doi.org/10.1055/s-0037-1610140","mag":"2803877790"},"language":"en","primary_location":{"id":"doi:10.1055/s-0037-1610140","doi":"https://doi.org/10.1055/s-0037-1610140","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0037-1610140","pdf_url":null,"source":{"id":"https://openalex.org/S197964166","display_name":"Synthesis","issn_l":"0039-7881","issn":["0039-7881","1437-210X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synthesis","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051345830","display_name":"Gregory L. Beutner","orcid":"https://orcid.org/0000-0001-8779-1404","observed_orcids":["https://orcid.org/0000-0001-8779-1404"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]},{"id":"https://openalex.org/I4210125795","display_name":"Bristol-Myers Squibb (United Kingdom)","ror":"https://ror.org/03emf1n04","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]}],"countries":["GB","US"],"is_corresponding":true,"raw_author_name":"Gregory Beutner","raw_affiliation_strings":["Chemical and Synthetic Development, Bristol-Myers Squibb Company"],"raw_orcid":"https://orcid.org/0000-0001-8779-1404","affiliations":[{"raw_affiliation_string":"Chemical and Synthetic Development, Bristol-Myers Squibb Company","institution_ids":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072262505","display_name":"William C. Wertjes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]},{"id":"https://openalex.org/I4210125795","display_name":"Bristol-Myers Squibb (United Kingdom)","ror":"https://ror.org/03emf1n04","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]}],"countries":["GB","US"],"is_corresponding":true,"raw_author_name":"William Wertjes","raw_affiliation_strings":["Chemical and Synthetic Development, Bristol-Myers Squibb Company"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical and Synthetic Development, Bristol-Myers Squibb Company","institution_ids":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032621433","display_name":"Sloan Ayers","orcid":"https://orcid.org/0000-0003-3562-1846","observed_orcids":["https://orcid.org/0000-0003-3562-1846"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]},{"id":"https://openalex.org/I4210125795","display_name":"Bristol-Myers Squibb (United Kingdom)","ror":"https://ror.org/03emf1n04","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]}],"countries":["GB","US"],"is_corresponding":true,"raw_author_name":"Sloan Ayers","raw_affiliation_strings":["Chemical and Synthetic Development, Bristol-Myers Squibb Company"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical and Synthetic Development, Bristol-Myers Squibb Company","institution_ids":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002612843","display_name":"Qi Gao","orcid":"https://orcid.org/0000-0001-5425-2471","observed_orcids":["https://orcid.org/0000-0001-5425-2471","https://orcid.org/0000-0003-0052-3621"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]},{"id":"https://openalex.org/I4210125795","display_name":"Bristol-Myers Squibb (United Kingdom)","ror":"https://ror.org/03emf1n04","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Qi Gao","raw_affiliation_strings":["Drug Product Sciences and Technology, Bristol-Myers Squibb Company"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Product Sciences and Technology, Bristol-Myers Squibb Company","institution_ids":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028469979","display_name":"Eric M. Simmons","orcid":"https://orcid.org/0000-0002-3854-1561","observed_orcids":["https://orcid.org/0000-0002-3854-1561"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]},{"id":"https://openalex.org/I4210125795","display_name":"Bristol-Myers Squibb (United Kingdom)","ror":"https://ror.org/03emf1n04","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]}],"countries":["GB","US"],"is_corresponding":true,"raw_author_name":"Eric Simmons","raw_affiliation_strings":["Chemical and Synthetic Development, Bristol-Myers Squibb Company"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical and Synthetic Development, Bristol-Myers Squibb Company","institution_ids":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5028469979","https://openalex.org/A5032621433","https://openalex.org/A5051345830","https://openalex.org/A5072262505"],"corresponding_institution_ids":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"],"apc_list":null,"apc_paid":null,"fwci":0.2046,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.36611722,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"50","issue":"22","first_page":"4453","last_page":"4461"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12318","display_name":"Quinazolinone synthesis and applications","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T12318","display_name":"Quinazolinone synthesis and applications","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10548","display_name":"Catalytic Cross-Coupling Reactions","score":0.007899999618530273,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10354","display_name":"Catalytic C\u2013H Functionalization Methods","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/quinazolinedione","display_name":"quinazolinedione","score":0.9919999837875366},{"id":"https://openalex.org/keywords/isocyanates","display_name":"isocyanates","score":0.9589999914169312},{"id":"https://openalex.org/keywords/isatoic-anhydride","display_name":"isatoic anhydride","score":0.996999979019165},{"id":"https://openalex.org/keywords/ligand-screening","display_name":"ligand screening","score":0.8870000243186951},{"id":"https://openalex.org/keywords/solvent-screening","display_name":"solvent screening","score":0.7860000133514404},{"id":"https://openalex.org/keywords/heterocycle-synthesis","display_name":"heterocyclic synthesis","score":0.7279999852180481}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9688875675201416},{"id":"https://openalex.org/C2780534471","wikidata":"https://www.wikidata.org/wiki/Q408365","display_name":"Isocyanate","level":3,"score":0.7323453426361084},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.6933839321136475},{"id":"https://openalex.org/C134121241","wikidata":"https://www.wikidata.org/wiki/Q899301","display_name":"Yield (engineering)","level":2,"score":0.6568020582199097},{"id":"https://openalex.org/C504270822","wikidata":"https://www.wikidata.org/wiki/Q744","display_name":"Nickel","level":2,"score":0.6453707218170166},{"id":"https://openalex.org/C118792377","wikidata":"https://www.wikidata.org/wiki/Q108584245","display_name":"Selectivity","level":3,"score":0.6316295862197876},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.5703659057617188},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.5626471042633057},{"id":"https://openalex.org/C2780471494","wikidata":"https://www.wikidata.org/wiki/Q146505","display_name":"Solvent","level":2,"score":0.47963079810142517},{"id":"https://openalex.org/C2778866207","wikidata":"https://www.wikidata.org/wiki/Q426278","display_name":"Quinazoline","level":2,"score":0.47698336839675903},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.40096810460090637},{"id":"https://openalex.org/C2779578285","wikidata":"https://www.wikidata.org/wiki/Q146322","display_name":"Polyurethane","level":2,"score":0.07891988754272461},{"id":"https://openalex.org/C191897082","wikidata":"https://www.wikidata.org/wiki/Q11467","display_name":"Metallurgy","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1055/s-0037-1610140","doi":"https://doi.org/10.1055/s-0037-1610140","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0037-1610140","pdf_url":null,"source":{"id":"https://openalex.org/S197964166","display_name":"Synthesis","issn_l":"0039-7881","issn":["0039-7881","1437-210X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synthesis","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W2003192950","https://openalex.org/W2020703322","https://openalex.org/W2033718035","https://openalex.org/W2047817641","https://openalex.org/W2085310493","https://openalex.org/W2098039857","https://openalex.org/W2144526646","https://openalex.org/W2328594897","https://openalex.org/W2338230418","https://openalex.org/W2513274461","https://openalex.org/W2518930122","https://openalex.org/W2587816765","https://openalex.org/W2783437170","https://openalex.org/W2951805139"],"related_works":["https://openalex.org/W2587816765","https://openalex.org/W2952049523","https://openalex.org/W2612407066","https://openalex.org/W1963485913","https://openalex.org/W1993572389","https://openalex.org/W2583375530","https://openalex.org/W2023867598","https://openalex.org/W2914225541","https://openalex.org/W2079036143","https://openalex.org/W2468407537"],"abstract_inverted_index":{"During":[0],"exploration":[1],"of":[2,6,20,41,55,61],"the":[3,17,21,62],"nickel(0)-catalyzed":[4],"reaction":[5],"isocyanates":[7],"and":[8,34,57],"isatoic":[9],"anhydrides,":[10],"it":[11],"was":[12],"found":[13],"that":[14,43],"changes":[15],"in":[16,50],"substitution":[18],"pattern":[19],"isocyanate":[22],"led":[23],"to":[24,46,52],"constitutionally":[25],"isomeric":[26],"quinazolinediones":[27],"[quinazoline-2,4(1H,3H)-diones]":[28],"or":[29],"benzoxazinone":[30,66],"imines":[31,67],"[2-imino-1,2-dihydro-4H-3,1-benzoxazin-4-ones].":[32],"Ligand":[33],"solvent":[35],"screening":[36],"experiments":[37],"allowed":[38],"for":[39],"identification":[40],"conditions":[42],"could":[44],"lead":[45],"each":[47],"constitutional":[48],"isomer":[49],"good":[51],"excellent":[53],"levels":[54],"selectivity":[56],"yield.":[58],"Comprehensive":[59],"characterization":[60],"previously":[63],"poorly":[64],"characterized":[65],"is":[68],"also":[69],"provided.":[70]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-06-01T00:00:00"}